Re: Breakthrough Therapy Designation Application
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 11:17AM
|
Re: one year vs two-year data
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 11:22AM
|
Re: Technically we're very oversold...
|
2
|
Resverlogix Corp.
|
Dec 17, 2019 03:27PM
|
Re: Technically we're very oversold...
|
1
|
Resverlogix Corp.
|
Dec 17, 2019 03:43PM
|
Re: Good News for Zenith
|
5
|
Zenith Epigenetics
|
Dec 19, 2019 05:05PM
|
Showcase 2020
|
2
|
Resverlogix Corp.
|
Dec 26, 2019 07:48AM
|
Re: Biotech Showcase, Jan 13-15
|
2
|
Resverlogix Corp.
|
Jan 07, 2020 11:56AM
|
Re: Biotech Showcase, Jan 13-15
|
1
|
Resverlogix Corp.
|
Jan 08, 2020 04:02PM
|
something. anything.
|
3
|
Zenith Epigenetics
|
Feb 28, 2020 02:21PM
|
Re: Hmmmmm.....
|
4
|
Resverlogix Corp.
|
Mar 09, 2020 01:10PM
|
Re: This Covid 19 possibility has
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 09:25AM
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Mar 29, 2020 05:37PM
|
Re: Zenith News
|
5
|
Zenith Epigenetics
|
May 05, 2020 05:35PM
|
Slide 6
|
1
|
Zenith Epigenetics
|
Jun 18, 2020 02:53PM
|
Re: Slide 6 - shows synergy with other listed drugs in the table
|
|
Zenith Epigenetics
|
Jun 19, 2020 06:25AM
|
Re: Slide 6 - shows synergy with other listed drugs in the table
|
4
|
Zenith Epigenetics
|
Jun 26, 2020 10:12AM
|
Re: Why is "Going it Alone" out of the question??
|
4
|
Resverlogix Corp.
|
Aug 15, 2020 12:45PM
|
Re: Zenith News
|
1
|
Zenith Epigenetics
|
Aug 27, 2020 08:12AM
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 09:50AM
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
1
|
Zenith Epigenetics
|
Oct 05, 2020 06:27PM
|